WallStreetZenWallStreetZen

NASDAQ: INDP
Indaptus Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INDP

Based on 1 analyst offering 12 month price targets for Indaptus Therapeutics Inc.
Min Forecast
$12.00+844.88%
Avg Forecast
$12.00+844.88%
Max Forecast
$12.00+844.88%

Should I buy or sell INDP stock?

Based on 1 analyst offering ratings for Indaptus Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INDP stock forecasts and price targets.

INDP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-17

1 of 1

Forecast return on equity

Is INDP forecast to generate an efficient return?
Company
-238.13%
Industry
15.12%
Market
50.04%
INDP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INDP forecast to generate an efficient return on assets?
Company
-180.79%
Industry
7.63%
INDP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INDP earnings per share forecast

What is INDP's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.72
Avg 2 year Forecast
-$1.44

INDP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INDP$1.27$12.00+844.88%Buy
EVGN$2.58$12.00+366.02%Strong Buy
EDSA$4.05$21.00+418.77%Buy
PMCB$1.73N/AN/A
IMRN$2.20$5.00+127.27%Strong Buy
View Top Biotech Stocks

Indaptus Therapeutics Stock Forecast FAQ

Is Indaptus Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: INDP) stock is to Buy INDP stock.

Out of 1 analyst, 0 (0%) are recommending INDP as a Strong Buy, 1 (100%) are recommending INDP as a Buy, 0 (0%) are recommending INDP as a Hold, 0 (0%) are recommending INDP as a Sell, and 0 (0%) are recommending INDP as a Strong Sell.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.

What is INDP's earnings growth forecast for 2024-2025?

(NASDAQ: INDP) Indaptus Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.57%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.05%.

Indaptus Therapeutics's earnings in 2024 is -$15,747,112.On average, 1 Wall Street analyst forecast INDP's earnings for 2024 to be -$17,538,640, with the lowest INDP earnings forecast at -$17,538,640, and the highest INDP earnings forecast at -$17,538,640.

In 2025, INDP is forecast to generate -$14,683,513 in earnings, with the lowest earnings forecast at -$14,683,513 and the highest earnings forecast at -$14,683,513.

What is INDP's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: INDP) forecast ROE is -238.13%, which is considered weak.

What is INDP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year INDP price target, the average INDP price target is $12.00, with the highest INDP stock price forecast at $12.00 and the lowest INDP stock price forecast at $12.00.

The Wall Street analyst predicted that Indaptus Therapeutics's share price could reach $12.00 by Jun 17, 2025. The average Indaptus Therapeutics stock price prediction forecasts a potential upside of 844.88% from the current INDP share price of $1.27.

What is INDP's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: INDP) Indaptus Therapeutics's current Earnings Per Share (EPS) is -$1.86. On average, analysts forecast that INDP's EPS will be -$1.72 for 2024, with the lowest EPS forecast at -$1.72, and the highest EPS forecast at -$1.72. In 2025, INDP's EPS is forecast to hit -$1.44 (min: -$1.44, max: -$1.44).

What is INDP's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: INDP) forecast ROA is -180.79%, which is lower than the forecast US Biotechnology industry average of 7.63%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.